Реальная клиническая практика: данные и доказательства

Publishing House OKI

Journal websitePeer review: Double-blind review
Evaluation status available after sign-in

About the journal

Реальная клиническая практика: данные и доказательства is an open-access journal published by Publishing House OKI in Russia, publishing in russian. It is listed in DOAJ according to the sources read. Declared review time at DOAJ: 8 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
Publishing House OKI
ISSN
2782-3784
Country
Russia
Languages
russian
Access
Open access
Articles in DOAJ
104
Declared review time
8 weeks
Declared peer-review model
double_blind
Official website
https://www.myrwd.ru/

Index listings

  • DOAJ · 2024-10-24
Indexing
DOAJ
APC
—
Declared review time (DOAJ)
8 weeks — journal-declared only (not measured)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Articles in DOAJ

104

Most recent article

3 months ago

Average review time (journal-declared via DOAJ)

8weeks

Works in OpenAlex

108

Last recorded publication year

2025

Reported by OpenAlex in 1 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

6

i10-index

3

From OpenAlex open data (CC0).

Editorial & policy8
Last DOAJ review date
2024-10-24
Added to DOAJ
2024-10-24
Declared plagiarism screening
Declared
Other fees beyond APC
Yes
Editorial board
Official page ↗
Open references deposited at Crossref
92%
ORCID iDs in current deposits
96%
Deposits licence metadata at Crossref
✓
Peer-review policy
View policy
Identity & continuity2
Alternate titles
Real-world data & evidence
Source type
journal
Classification2

Subjects (DOAJ)

Medicine: Medicine (General)

LCC codes

R5-920

Subject areas

  • Health Systems, Economic Evaluations, Quality of Life
  • Health Systems, Economic Evaluations, Quality of Life
  • Healthcare Systems and Public Health
  • Healthcare Systems and Public Health
  • Pharmaceutical Economics and Policy
  • Pharmaceutical Economics and Policy
  • Computational Drug Discovery Methods
  • Computational Drug Discovery Methods
Show all subjects (50)
  • Pharmacovigilance and Adverse Drug Reactions
  • Pharmacovigilance and Adverse Drug Reactions
  • Statistical Methods in Clinical Trials
  • Healthcare cost, quality, practices
  • Pharmaceutical studies and practices
  • Healthcare cost, quality, practices
  • Pharmaceutical studies and practices
  • Statistical Methods in Clinical Trials
  • Health and Medical Research Impacts
  • Health and Medical Research Impacts
  • Ethics in Clinical Research
  • Ethics in Clinical Research
  • Biomedical Ethics and Regulation
  • Economic and Financial Impacts of Cancer
  • Biosimilars and Bioanalytical Methods
  • Biosimilars and Bioanalytical Methods
  • Biomedical Ethics and Regulation
  • Bacterial Infections and Vaccines
  • Artificial Intelligence in Healthcare and Education
  • Meta-analysis and systematic reviews
  • Vaccine Coverage and Hesitancy
  • Artificial Intelligence in Healthcare and Education
  • Advanced Causal Inference Techniques
  • Advanced Breast Cancer Therapies
  • Antibiotic Use and Resistance
  • Bacterial Infections and Vaccines
  • Advanced Causal Inference Techniques
  • Economic and Financial Impacts of Cancer
  • Meta-analysis and systematic reviews
  • Vaccine Coverage and Hesitancy
  • Advanced Breast Cancer Therapies
  • Pharmaceutical Practices and Patient Outcomes
  • Antibiotic Use and Resistance
  • Venous Thromboembolism Diagnosis and Management
  • Pharmaceutical Practices and Patient Outcomes
  • Pneumonia and Respiratory Infections
  • Inflammatory mediators and NSAID effects
  • Breast Cancer Treatment Studies
  • Inflammatory mediators and NSAID effects
  • Breast Cancer Treatment Studies
  • Venous Thromboembolism Diagnosis and Management
  • Pneumonia and Respiratory Infections

Keywords (DOAJ)

  • real-world studies
  • real clinical practice research
  • non-interventional studies
  • real clinical practice
  • real-world evidence
  • real-world data

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: